Movicol and Status epilepticus - a phase IV clinical study of FDA data

Summary:

Status epilepticus is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are female, 60+ old, also take Keppra, and have Depression.

The phase IV clinical study analyzes which people have Status epilepticus when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Status epilepticus?

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure) is found to be associated with 663 drugs and 949 conditions by eHealthMe. Check the latest studies of Status epilepticus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14,199 people reported to have side effects when taking Movicol.
Among them, 24 people (0.17%) have Status epilepticus.

Among these 24 people:

What is the gender of people who have Status epilepticus when taking Movicol? *

female: 55 %
male: 45 %

What is the age of people who have Status epilepticus when taking Movicol? *

What are other drugs people take besides Movicol? *

What are other side effects people have besides Status epilepticus? *

Swallowing Difficulty: 7 people, 29.17%
Diplopia (double vision): 6 people, 25.00%
Fall: 5 people, 20.83%
Fatigue (feeling of tiredness): 5 people, 20.83%
Fever: 5 people, 20.83%
Escherichia Urinary Tract Infection (urinary tract infection by escherichia coli): 4 people, 16.67%
Leukopenia (less number of white blood cells in blood): 4 people, 16.67%
Leukoencephalopathy (disease of the white matter in the brain): 4 people, 16.67%
Inflammation: 4 people, 16.67%
Hyperventilation: 4 people, 16.67%

What are the existing conditions these people have? *

Insomnia (sleeplessness): 6 people, 25.00%
Depression: 6 people, 25.00%
Partial Seizures (seizures which affect only a part of the brain at onset): 5 people, 20.83%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 16.67%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 4 people, 16.67%
Gait Disturbance: 4 people, 16.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 4 people, 16.67%
Abnormal Behavior: 4 people, 16.67%
Urogenital Infection Bacterial: 1 person, 4.17%
Pain: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and have Status epilepticus?

- Check whether Status epilepticus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Movicol:

Movicol (14,249 reports)

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Status epilepticus:

Status epilepticus (663 drugs)

Browse all the conditions that are associated with Status epilepticus:

Status epilepticus (949 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.